In at the Deep End: What Cold Water Swimming Is Teaching Life Sciences

The largest meta-analysis yet of cold-water immersion has found it does the opposite of one of its most-repeated claims, actually raising inflammation markers rather than lowering them, at least in the first hour. A rat study has traced a specific molecular pathway by which cold swimming turns energy-storing white fat into heat-generating brown fat. And a small UK diary study has shown, day by day, exactly what changes in a regular sea swimmer’s anxiety and sleep on the days they get in the water. Cold water swimming has gone from niche pastime to wellness mainstay largely on the strength of testimony. In 2025, the evidence started catching up, and it isn’t giving a simple answer.

Open-water and cold-plunge culture has grown fast enough that ice bath sales on Amazon reportedly rose from under 1,000 units to more than 90,000 in a single year, far outpacing the quality of evidence behind the claims sold alongside them. Three pieces of recent research show what happens when that culture gets tested with the same rigour applied to a drug or a medical device.

The Meta-Analysis That Complicates the Wellness Narrative

The most rigorous test yet of cold-water immersion’s general health claims arrived in January 2025, when Tara Cain and colleagues at the University of South Australia published a systematic review and meta-analysis in PLOS ONE, pooling 11 randomised trials and 3,177 healthy adults exposed to water at 7°C to 15°C via ice baths, plunges or cold showers. The results cut against the popular narrative in one important respect: rather than reducing inflammation, cold-water immersion produced a significant increase in inflammatory markers immediately afterwards and again at one hour, before that response presumably resolves. Immune function showed no significant change in the pooled trial data, though the researchers noted a striking finding from outside the meta-analysis proper, a Dutch trial of daily cold showers linking the practice to a 29% reduction in workplace sickness absence. Stress levels fell significantly, but only at the 12-hour mark, not immediately or at any other measured point, and sleep quality and quality-of-life measures improved while mood did not. The authors were candid about the limits of what they had to work with: few trials, small samples, narrow study populations, and a research base that has not kept pace with the trend it is meant to be evaluating. It is a genuinely useful corrective, not a debunking, showing a practice with real, measurable, time-dependent effects that are more specific and more modest than the claims usually made for it.

Why a Cold Swim Might Turn Fat Into Heat

The second piece of research explains, at a molecular level, one of the more plausible claims made for cold swimming: that it can convert energy-storing white fat into heat-generating brown fat. Publishing in Molecular Biology Reports in August 2024, a team led by Niloofar Rahmani at Kharazmi University in Tehran, working with US and Japanese collaborators including Kurt Escobar and Katsuhiko Suzuki, put 24 male Wistar rats through six weeks of swimming training, some in neutral water, some at 15°C, three days a week, until exhaustion. The rats that swam in cold water gained less body weight and showed the clearest activation of the browning process: lower levels of myostatin, a protein that normally restrains this kind of tissue remodelling, alongside higher expression of the genes IRF4 and PGC-1α and of UCP1, the protein that lets brown fat burn energy as heat rather than storing it. The researchers concluded that myostatin suppression appears to regulate the PGC-1α-UCP1 pathway that drives fat browning, giving cold-water advocates something they have mostly lacked: a specific, testable mechanism rather than an association. It is worth being precise about what this does and does not show. This is rodent research, not a human trial, and rats regulate heat and fat differently enough from people that the finding should be read as a plausible mechanism worth investigating in humans, not as proof cold swimming reshapes human fat tissue the same way.

What Actually Changes on Swim Days

The third piece of research is smaller and more human in scale. Jill Forsten and Mark Wetherell at Northumbria University published a diary study in Lifestyle Medicine in July 2025, tracking 13 healthy, regular female cold-water sea swimmers in the UK who completed short questionnaires twice a day, morning and evening, whether or not they had swum, recording anxiety, self-confidence, sleep quality and general wellness. Comparing swim days against non-swim days within the same individuals let the researchers isolate something broader surveys and one-off lab studies cannot: what changes, day to day, for people who already swim regularly. The results were consistent across several measures: swim days brought significant reductions in anxiety and increases in self-confidence, along with better self-reported sleep and lower anxiety the following morning. The sample is small and self-selected, and the study makes no claim to have identified a mechanism, but as the first study to use a daily diary method in this specific population, it adds something the larger, more clinical trials struggle to capture: a granular, repeated-measures picture of what a cold swim actually does to how someone feels that day and the next morning. A larger, fully powered UK trial testing outdoor swimming against usual care for people with diagnosed depression, called OUTSIDE 2, has been recruiting since 2024 and will offer a considerably stronger test of the same question.

Testing a Practice That Outran Its Evidence

What connects a meta-analysis that overturns a popular claim, a rat study identifying a specific fat-browning pathway, and a diary study of thirteen swimmers is a field playing catch-up with a trend that scaled far faster than the science behind it. None of the three studies is a wholesale endorsement, and none is a debunking either. Cold water swimming looks, on the current evidence, less like the universal fix wellness culture often sells and more like a genuinely interesting intervention with real but specific effects, on stress at 12 hours rather than immediately, on fat metabolism in rats rather than confirmed yet in humans, on anxiety and sleep within a small and self-selected group of committed swimmers. That is precisely the kind of evidence life sciences needs before a cold plunge can move from wellness trend to something closer to a genuine tool for managing metabolic or mental health, and the trials now underway, particularly the fully powered OUTSIDE 2 study, should sharpen that picture considerably over the next year.

Sources include PLOS ONE, Molecular Biology Reports, Lifestyle Medicine, Northumbria University and the National Institute for Health and Care Research.

Author

Leave A Comment

Graham Combe

Strategic Consultant,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Graham Combe is an experienced strategic consultant, relationship builder, and entrepreneur in the global life sciences sector. He holds a BSc (Hons) in Chemistry from University College London (UCL) and spent over a decade with Nature, where he pioneered key initiatives such as Nature’s BioPharma Dealmakers and Nature’s SciCafe.

In May 2011, he founded Biosell UK, a consulting and event management firm that collaborates with global life science publishers, event organizations, and marketing partners. Beyond BioSell, Combe is the founder or co-founder of several prominent networking and thought-leadership platforms, including #BiotechBuddies, #coffeebuddies, the #AgileLeaders Forum, and the Creative Disruption Forum—the latter three events co-hosted with his business partner, Professor Tony Sedgwick.

Specializing in the early-to-mid stages of drug development (from pre-clinical research through Phase 3 and clinical proof-of-concept), Graham focuses on facilitating forums to promote peer-to-peer discussion, strategic growth, investment and meaningful connections between biotech innovators, investors, and industry service providers.

Secure your Launch Day Conference Pass

Be in the room where the future of life sciences is shaped.

Early Bird until 31 August: Save £155

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details